Examlex

Solved

The Following Information Is Related to the Short-Term Passive Investments

question 92

Multiple Choice

The following information is related to the short-term passive investments of Solo Company. Securities held on December 31, 2016 are described in the table below.
 Securities  No. of  Cost/Share  Total  Value/Share  Total Market  Shares  Cost  Value  AAA 100$29$2,900$34$3,400 BBB 250307,500287,000 CCC 150162,400203,000$12,800$13,400\begin{array}{|r|r|r|r|r|r|}\hline\text { Securities } &\text { No. of }& \text { Cost/Share } &\text { Total } & \text { Value/Share } &\text { Total Market } \\&\text { Shares }&&\text { Cost }&&\text { Value }\\\hline\text { AAA } & 100 & \$ 29 & \$ 2,900 & \$ 34 & \$ 3,400 \\\hline \text { BBB } & 250 & 30 & 7,500 & 28 & 7,000 \\\hline \text { CCC } & 150 & 16 & 2,400 & 20 & 3,000 \\\hline&&&\$12,800&&\$13,400\\\hline\end{array}
Early in 2017, the company sold 50 shares of BBB for $26 per share. During 2017, Solo received dividends of $3 per share on the remaining 200 shares of BBB, and dividends of $2.50 per share were declared, but not yet received on the 150 shares of CCC stock. The per-share market values of BBB and CCC on December 31, 2017, were $24 and $18, respectively. During 2018, Solo sold the remaining 200 shares of BBB stock for $26 per share and the 150 shares of CCC for $22 per share.
The journal entries to record the dividends received on the BBB securities and the dividends declared on the CCC stock in 2017 will include:


Definitions:

Category I Task

A designation for tasks that are considered top priority or utmost importance in a given context.

Standard Precautions

Basic infection prevention practices aimed at reducing the risk of transmission of infectious agents from recognized and unrecognized sources.

Needlestick Prevention

Measures and practices designed to reduce the risk of injury from needles and other sharp medical instruments.

Specific Recommendations

Guidelines or advice tailored to address particular concerns or situations.

Related Questions